272 related articles for article (PubMed ID: 11751507)
1. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.
Kawakami K; Salonga D; Park JM; Danenberg KD; Uetake H; Brabender J; Omura K; Watanabe G; Danenberg PV
Clin Cancer Res; 2001 Dec; 7(12):4096-101. PubMed ID: 11751507
[TBL] [Abstract][Full Text] [Related]
2. Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer.
Ishida Y; Kawakami K; Tanaka Y; Kanehira E; Omura K; Watanabe G
Anticancer Res; 2002; 22(5):2805-9. PubMed ID: 12530000
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
[TBL] [Abstract][Full Text] [Related]
4. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer.
Merkelbach-Bruse S; Hans V; Mathiak M; Sanguedolce R; Alessandro R; Rüschoff J; Büttner R; Houshdaran F; Gullotti L
Oncol Rep; 2004 Apr; 11(4):839-43. PubMed ID: 15010882
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers.
Kawakami K; Omura K; Kanehira E; Watanabe Y
Anticancer Res; 1999; 19(4B):3249-52. PubMed ID: 10652619
[TBL] [Abstract][Full Text] [Related]
6. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.
Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
Eur J Cancer; 2005 Sep; 41(14):2176-83. PubMed ID: 16182121
[TBL] [Abstract][Full Text] [Related]
7. Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer.
Calascibetta A; Cabibi D; Martorana A; Sanguedolce G; Rausa L; Feo S; Dardanoni G; Sanguedolce R
Anticancer Res; 2004; 24(6):3875-80. PubMed ID: 15736425
[TBL] [Abstract][Full Text] [Related]
8. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene.
Kawakami K; Watanabe G
Cancer Res; 2003 Sep; 63(18):6004-7. PubMed ID: 14522928
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ
Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929
[TBL] [Abstract][Full Text] [Related]
11. [Thymidylate synthase gene promoter polymorphism in patients with advanced head and neck cancer treated by radio- and 5-fluorouracil chemotherapy].
Kiss-László Z; Nagy B; Thurzó L; Szabó J
Magy Onkol; 2006; 50(1):33-7. PubMed ID: 16617381
[TBL] [Abstract][Full Text] [Related]
12. Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy.
Brody JR; Hucl T; Gallmeier E; Winter JM; Kern SE; Murphy KM
Cancer Res; 2006 Oct; 66(19):9369-73. PubMed ID: 17018589
[TBL] [Abstract][Full Text] [Related]
13. [The association of expression and gene polymorphism of the thymidylate synthase gene with 5-fluoro-5'-deoxyuridine sensitivity in gastric cancer cell lines].
Kaneko M; Kawakami K; Oyama K; Endo Y; Tanaka M; Sasaki T; Watanabe G
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1347-50. PubMed ID: 15446554
[TBL] [Abstract][Full Text] [Related]
14. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.
Johnston PG; Lenz HJ; Leichman CG; Danenberg KD; Allegra CJ; Danenberg PV; Leichman L
Cancer Res; 1995 Apr; 55(7):1407-12. PubMed ID: 7882343
[TBL] [Abstract][Full Text] [Related]
15. A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity.
Mandola MV; Stoehlmacher J; Muller-Weeks S; Cesarone G; Yu MC; Lenz HJ; Ladner RD
Cancer Res; 2003 Jun; 63(11):2898-904. PubMed ID: 12782596
[TBL] [Abstract][Full Text] [Related]
16. The presence of three repeats in the 5' UTR region of thymidylate synthase (TS) is associated with increased TS mRNA expression in cultured human cancer cell lines in vitro.
Hammad H; Sarkar M; Gupta N; Ardalan B; Subbarayan PR
Oncol Rep; 2012 Jan; 27(1):246-9. PubMed ID: 21947036
[TBL] [Abstract][Full Text] [Related]
17. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.
Fernández-Contreras ME; Sánchez-Hernández JJ; González E; Herráez B; Domínguez I; Lozano M; García De Paredes ML; Muñoz A; Gamallo C
Int J Oncol; 2009 Jan; 34(1):219-29. PubMed ID: 19082493
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase polymorphism and microsatellite instability: association in colorectal cancer.
Calascibetta A; Rausa L; Gullotti L; Buettner R; Sanguedolce R
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1377-9. PubMed ID: 15571262
[TBL] [Abstract][Full Text] [Related]
19. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil.
Iacopetta B; Grieu F; Joseph D; Elsaleh H
Br J Cancer; 2001 Sep; 85(6):827-30. PubMed ID: 11556832
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of thymidylate synthase gene 5'- and 3'-untranslated region and risk of gastric cancer in Koreans.
Yim DJ; Kim OJ; An HJ; Kang H; Ahn DH; Hwang SG; Oh D; Kim NK
Anticancer Res; 2010 Jun; 30(6):2325-30. PubMed ID: 20651387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
